Inspire is the world’s largest online health community, patient engagement and real-world data platform. More than 10 million people come to Inspire each year to find peer support for more than 3,000 conditions.Inspire also works with leading biopharmaceutical companies and academic researchers to provide real-world evidence and insights about the patient experience, connect patients with life-advancing clinical trials, and enable medical breakthroughs. We’ve helped accelerate research progress for more than 90 diseases, including heart disease, Alzheimer’s, and ovarian, prostate and lung cancer through these partnerships. Learn more at about.Inspire.com.In this role, I am responsible for building and growing the RWE business unit -- commercializing our patient-centered real world data and evidence platform to support various stakeholders working on medical products from discovery through commercial and post-marketing approval.

Inspire is the vital community for millions of patients and caregivers with the mission to accelerate life-changing discoveries for health. Partnering with over 100 organizations, including the American Lung Association, National Psoriasis Foundation, Ovarian Cancer National Alliance, the Arthritis Foundation, and the Alzheimer’s Foundation of America, Inspire provides support for more than 2 million patients and caregivers, and helps industry deliver meaningful impact and improve outcomes. At Inspire, I focus on developing our marketing and brand strategy for growing our patient community as well as our customers (B2B).

We are a non-profit organization that gives families afflicted by rare genetic disorders access to genome sequencing and additional personalized rare disease research. We bring together scientists who share our passion for helping rare disease patients and leverage the crowdfunding capabilities of the Internet to bring the hope of a cure to our patients

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.With over 25 years of experience and managing more than 170 million biological samples in their repositories, Fisher BioServices' highly trained team of experts, specialized processes, and unique capabilities ensure that they meet your expectations. The company delivers unmatched options for a complete biobanking solution, from sample collection, receipt, accessioning, barcode-based chain-of-custody tracking, inventory management supporting web-based sample queries, and global distribution to support your basic research and clinical study programs.

HBN’s mission is to create a stronger biotech community which addresses the interests of its 2500+ members. We at HBN focus on critical issues in biotechnology and seek to bridge the gap between the three main stakeholders (our members) in the biotech field: industry, academia, and government.http://www.linkedin.com/groups/Hopkins-Biotech-Network-153027

OpGen’s Whole Genome Mapping technology, formerly “Optical” Mapping technology, provides innovative tools for genomic sequence assembly and finishing, microbial strain comparison and species characterization. Our mission is to positively influence individual healthcare outcomes, advance scientific research, and enhance public health by delivering precise, actionable information and results to customers in the life science and healthcare communities. Our customers are focused on DNA sequencing, epidemiology, outbreak identification, microbial forensics, biodefense and pharmaceutical discovery

The Johns Hopkins Technology Transfer Office (JHTT) is the University’s intellectual property administration center, serving Johns Hopkins researchers and inventors as a licensing, patent, and technology commercialization office and acting as an active liaison to parties interested in leveraging JHU research or materials for academic or corporate endeavors.

Founded in 2003, Eton Bioscience, Inc. is a privately-held company located in beautiful San Diego, we provide the biological research communities of academia and industry with services which assist them in their ongoing experiments and investigations. Our services include DNA sequencing, gene synthesis, gene expression, genomic products, and much more!- Led to a growth of more than 100% in sales and 300% growth in accounts in the east coast terroritories

Solix BioSystems is the leading provider of integrated solutions and services that enable large scale cultivation of algae.Solix’s highly scalable, Lumian™ algal production systems enable large-scale, cost efficient production of crude algae products that are competitive with equivalent products derived from fossil fuels or produced from land crops. The Lumian system is robust enabling it to be deployed in a wide range of environmental conditions. Solix works with partners interested in using its Lumian technology to produce products derived from algae.

I2BF Global Ventures is an international clean technology asset management group with a global investment mandate. I2BF Global Ventures operates two separate divisions: I2BF Venture Capital and I2BF Public Equities; focused on venture capital and public equity activities respectively. Established in 2005, I2BF has over USD 145 million in assets under management across, I2BF Holdings I (a collection of managed accounts and investment vehicles) which has over USD 110 million committed and made its first investment in 2006, I2BF Venture Fund II and the long/short quantiative hedge fund, I2BF Arbat Clean Technology Fund launched in 2008.In keeping with its worldwide focus, I2BF retains a team of technology and sector experts as well as renewable energy researchers across teams in New York, London, Moscow and Dubai.

The highest academic institution in Taiwan. It is engaged in conducting scientific research in its own institutes, spanning across many disciplines. - peptide synthesis & purification of small proteins- cancer drug development